News tagged with erlotinib

Related topics:

Assessing positive outcomes of phase III trials

Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online December 3rd in ...

dateDec 03, 2010 in Cancer
shares0 comments 0